Biological Information
Background Information:
Peroxisomes proliferators include hypolipidemic drugs, leukotriene receptor antagonists and other materials. The term is used because they induce an increase in the size and number of peroxisomes, which are subcellular organelles found in animals and plants that contain enzymes for respiration and for cholesterol and lipid metabolism. The action of peroxisome proliferators is thought to be mediated via specific receptors, called PPARs, which belong to the steroid hormone receptor superfamily that function as transcription factors regulating the expression of genes. All PPARs heterodimerase with the retinoid X receptor (RXR) and bind to specific regions on the DNA of target genes. PPARs play essential roles in the regulation of cellular differentiation, development, and metabolism (carbohydrate, lipid, protein) of higher organisms. Three closely related subtypes (alpha, beta/delta, and gamma) have been identified. PPARG (PPARγ) is expressed in three forms: γ1 is expressed in virtually all tissues including heart, muscle, colon, kidney, pancreas and spleen while γ2 is expressed mainly in adipose tissue liver, kidney, heart, muscle, adipose tissue and γ3 is expressed in macrophages, large intestine and white adipose tissue. PPARG, stimulated by the drug class of thiazolidinediones (TZDs), is used in the treatment of diabetes mellitus and other diseases that feature insulin resistance; PPARG stimulation may also be used for the treatment of obesity, hypolipidemia and several cancers. Inhibition of PPARG may enhance tumorigenesis.
PathHunter NHR Protein Interaction cell lines are engineered to co-express a ProLink™ (PK) tagged NHR and an Enzyme Acceptor (EA) tagged SRC protein. Activation of the receptor results in SRC-EA recruitment, forcing complementation of the two β-galactosidase enzyme fragments (EA and PK). The resulting functional enzyme hydrolyzes substrate to generate a chemiluminescent signal.
Family:
NHR
Sub Family:
Peroxisome Proliferator-Activated
Class:
Non-Steroid
Protein Name:
PPARgamma
Uniprot Number:
P37231
Protein Aliases:
Nuclear receptor subfamily 1 group C member 3
Gene Name:
PPARG
Gene ID:
5468
Gene Aliases:
PPARG1|PPARG2|NR1C3|PPARgamma
Accession Number:
NM_138711
Organism:
Human
Cell Type:
CHO-K1
Assay Information
Assay Type:
Functional
Assay Sub Type:
Cell Based
Functional Mode:
Antagonist
Testing Information
Control Activator:
Troglitazone
Test Concentration / Dose:
Eurofins will provide IC/EC50 calculation if 10 concentrations are selected
Test Sample Requirements:
40uL of a 1000X stock for the first assay and 2uL for each additional assay (assay = 1 target, 1 readout, 1 mode)
Minimum Order Quantity:
20
Turnaround Time
Standard:
15 Business Days
Clinical Relevance
Adverse / Beneficial Action:
PPARG, stimulated by the drug class of thiazolidinediones (TZDs), is used in the treatment of diabetes mellitus and other diseases that feature insulin resistance; PPARG stimulation may also be used for the treatment of obesity, hypolipidemia and several cancers. PPAR is also midly stimulated by some NSAIDs (e.g., ibuprofen) and indoles. Inhibition of PPARG may enhance tumorigenesis.
Additional Information
Brand:
LeadHunter
Testing Location:
USA - Fremont, CA